PBS Website Update - 1 March 2022

The Schedule of Pharmaceutical Benefits was updated on 1 March 2022 and the Summary of Changes can be found on the New, Amended and Deleted Items page.

The following updates have also been made to the PBS Website.

• Formulary Allocations -  1 March 2022
• Ex-manufacturer price - 1 March 2022
• Drugs subject to Price Disclosure - 1 March 2022
• Medicine Status Website - 1 March 2022
• Price Disclosure Reductions for 2022 April Cycle - 28 February 2022
• PBAC Recommendation for molnupiravir (Lagevrio®) February 2022 - 25 February 2022
• PBS Process Improvements - 23 February 2022
• Key Performance Measures for the Seventh Community Pharmacy Agreement (7CPA) - 23 February 2022
• PBS Arrangements for medicines for the treatment of paroxysmal nocturnal haemoglobinuria - 21 February 2022
• Seventh Community Pharmacy Agreement (7CPA) Consultation Committees - 18 February 2022
• The Closing the Gap (CTG) - PBS Co-payment Program - 17 February 2022
• PBS and RPBS Section 85 Date of Supply Data - 16 February 2022
• Agenda for the May 2022 PBAC Intracycle meeting - 11 February 2022
• Health Products Portal Industry Webinars - 9 February 2022
• Health Products Portal - Frequently Asked Questions - 9 February 2022
• Frequently Asked Questions - 9 February 2022
• Health Products Portal - Quick Reference Guides - 9 February 2022
• Review of the National Medicines Policy – Consultation on Draft National Medicines Policy Extended – Closes 2 March 2022 - 8 February 2022
• Pharmacist Substitution of PBS Medicines without a Prescription during Shortages (Serious Scarcity Substitution Instrument) - 8 February 2022
• Stakeholder Consultation Forum: Post-Market Review of Opiate Dependence Treatment Program Medicines - 3 February 2022
• Review of the National Medicines Policy – Consultation on the Draft of the National Medicines Policy – Closes Wednesday 16 February 2022 - 2 February 2022